Weiss Multi Strategy Advisers LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Weiss Multi Strategy Advisers LLC

$0
Q1 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$83.14 - $145.99 $475,976 - $835,792	-5,725 Reduced 8.71%	60,000 $8.74 Million
Q1 2022 May 16, 2022	SELL	$110.08 - $142.92 $761,753 - $989,006	-6,920 Reduced 9.53%	65,725 $7.79 Million
Q4 2021 Feb 14, 2022	SELL	$99.73 - $148.48 $234,864 - $349,670	-2,355 Reduced 3.14%	72,645 $10 Million
Q3 2021 Nov 15, 2021	SELL	$98.85 - $138.91 $1.62 Million - $2.27 Million	-16,372 Reduced 17.92%	75,000 $10.4 Million
Q2 2021 Aug 16, 2021	BUY	$65.78 - $105.02 $175,040 - $279,458	2,661 Added 3.0%	91,372 $8.87 Million
Q1 2021 May 14, 2021	BUY	$64.07 - $91.75 $3.11 Million - $4.45 Million	48,515 Added 120.7%	88,711 $6.06 Million
Q4 2020 Feb 16, 2021	SELL	$65.07 - $98.24 $2.79 Million - $4.21 Million	-42,804 Reduced 51.57%	40,196 $3.45 Million
Q3 2020 Nov 16, 2020	SELL	$59.04 - $77.95 $1,062 - $1,403	-18 Reduced 0.02%	83,000 $5.4 Million
Q2 2020 Aug 14, 2020	SELL	$29.01 - $74.23 $81,779 - $209,254	-2,819 Reduced 3.28%	83,018 $6.07 Million
Q1 2020 May 15, 2020	SELL	$27.51 - $57.29 $252,074 - $524,948	-9,163 Reduced 9.65%	85,837 $2.92 Million
Q4 2019 Feb 14, 2020	SELL	$40.86 - $57.65 $408,600 - $576,500	-10,000 Reduced 9.52%	95,000 $5.17 Million
Q3 2019 Nov 14, 2019	SELL	$37.38 - $49.47 $784,980 - $1.04 Million	-21,000 Reduced 16.67%	105,000 $4.38 Million
Q2 2019 Aug 14, 2019	BUY	$39.79 - $67.01 $4.62 Million - $7.77 Million	116,000 Added 1160.0%	126,000 $5.52 Million
Q1 2019 May 15, 2019	SELL	$34.52 - $53.29 $34,520 - $53,290	-1,000 Reduced 9.09%	10,000 $515,000
Q4 2018 Feb 14, 2019	SELL	$29.75 - $42.9 $119,000 - $171,600	-4,000 Reduced 26.67%	11,000 $407,000
Q3 2018 Nov 14, 2018	BUY	$32.79 - $43.0 $229,530 - $301,000	7,000 Added 87.5%	15,000 $563,000
Q2 2018 Aug 14, 2018	BUY	$23.62 - $42.29 $188,960 - $338,320	8,000 New	8,000 $316,000

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.

Account